Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells - PubMed (original) (raw)
. 2004 Aug;16(8):1189-201.
doi: 10.1093/intimm/dxh122. Epub 2004 Jul 5.
Affiliations
- PMID: 15237110
- DOI: 10.1093/intimm/dxh122
Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells
Eiji Nishimura et al. Int Immunol. 2004 Aug.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T (T(R)) cells can be exploited to establish immunologic tolerance to non-self antigens. In vivo exposure of CD25(+)CD4(+) T cells from normal naive mice to alloantigen in a T cell-deficient environment elicited spontaneous expansion of alloantigen-specific CD25(+)CD4(+) T(R) cells, which suppressed allograft rejection mediated by subsequently transferred naive T cells, leading to long-term graft tolerance. The expanded T(R) cells, which became CD25(low) in the absence of other T cells, stably sustained suppressive activity, maintained expression levels of other T(R) cell-associated molecules, including Foxp3, CTLA-4 and GITR, and could adoptively transfer tolerance to normal mice. Furthermore, specific removal of the T(R) cells derived from originally transferred CD25(+)CD4(+) T(R) cells evoked graft rejection in the long-term tolerant mice, indicating that any T(R) cells deriving from CD25(-)CD4(+) naive T cells minimally contribute to graft tolerance and that natural T(R) cells are unable to infectiously confer significant suppressive activity to other T cells. Similar antigen-specific expansion of T(R) cells can also be achieved in vitro by stimulating naturally present CD25(+)CD4(+) T cells with alloantigen in the presence of IL-2. The expanded CD25(+)CD4(+) T cells potently suppressed even secondary MLR in vitro and, by in vivo transfer, established antigen-specific long-term graft tolerance. Thus, in vivo or in vitro, direct or indirect ways of antigen-specific expansion of naturally arising Foxp3(+)CD25(+)CD4(+) T(R) cells can establish antigen-specific dominant tolerance to non-self antigens, and would also be instrumental in re-establishing self-tolerance in autoimmune disease and antigen-specific negative control of pathological immune responses.
Similar articles
- Induction of tolerance by adoptive transfer of Treg cells.
Nagahama K, Nishimura E, Sakaguchi S. Nagahama K, et al. Methods Mol Biol. 2007;380:431-42. doi: 10.1007/978-1-59745-395-0_27. Methods Mol Biol. 2007. PMID: 17876110 Review. - In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI. Tsang J, et al. Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8. doi: 10.1016/j.intimp.2006.07.032. Epub 2006 Sep 1. Int Immunopharmacol. 2006. PMID: 17161341 - In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
Jiang S, Golshayan D, Tsang J, Lombardi G, Lechler RI. Jiang S, et al. Int Immunopharmacol. 2006 Dec 20;6(13-14):1879-82. doi: 10.1016/j.intimp.2006.07.025. Epub 2006 Aug 15. Int Immunopharmacol. 2006. PMID: 17161340 - Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, Sakaguchi S. Yagi H, et al. Int Immunol. 2004 Nov;16(11):1643-56. doi: 10.1093/intimm/dxh165. Epub 2004 Oct 4. Int Immunol. 2004. PMID: 15466453 - Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Yamazaki S, et al. Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
Cited by
- Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.
Dittmar DJ, Pielmeier F, Strieder N, Fischer A, Herbst M, Stanewsky H, Wenzl N, Röseler E, Eder R, Gebhard C, Schwarzfischer-Pfeilschifter L, Albrecht C, Herr W, Edinger M, Hoffmann P, Rehli M. Dittmar DJ, et al. Nat Commun. 2024 Apr 15;15(1):3224. doi: 10.1038/s41467-024-47575-z. Nat Commun. 2024. PMID: 38622133 Free PMC article. - Too much of a good thing: a review of primary immune regulatory disorders.
Tsilifis C, Slatter MA, Gennery AR. Tsilifis C, et al. Front Immunol. 2023 Oct 31;14:1279201. doi: 10.3389/fimmu.2023.1279201. eCollection 2023. Front Immunol. 2023. PMID: 38022498 Free PMC article. Review. - Regulatory T cells in autoimmune kidney diseases and transplantation.
Mikami N, Sakaguchi S. Mikami N, et al. Nat Rev Nephrol. 2023 Sep;19(9):544-557. doi: 10.1038/s41581-023-00733-w. Epub 2023 Jul 3. Nat Rev Nephrol. 2023. PMID: 37400628 Review. - Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective.
Sakaguchi S, Kawakami R, Mikami N. Sakaguchi S, et al. Immunother Adv. 2023 Apr 21;3(1):ltad007. doi: 10.1093/immadv/ltad007. eCollection 2023. Immunother Adv. 2023. PMID: 37397971 Free PMC article. Review. - Leverage biomaterials to modulate immunity for type 1 diabetes.
Jing Z, Li Y, Ma Y, Zhang X, Liang X, Zhang X. Jing Z, et al. Front Immunol. 2022 Nov 2;13:997287. doi: 10.3389/fimmu.2022.997287. eCollection 2022. Front Immunol. 2022. PMID: 36405706 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials